Cargando…
HCQ use not protective against SARS-CoV-2
Autor principal: | Onuora, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573861/ https://www.ncbi.nlm.nih.gov/pubmed/33082565 http://dx.doi.org/10.1038/s41584-020-00529-3 |
Ejemplares similares
-
SARS-CoV-2 vaccine safe for young patients
por: Onuora, Sarah
Publicado: (2022) -
Analogue discovery of safer alternatives to HCQ and CQ drugs for SAR-CoV-2 by computational design
por: Sinha, Meetali, et al.
Publicado: (2021) -
Cross-viral protection against SARS-CoV-2?
por: Reed, Sophie G.
Publicado: (2020) -
Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020) -
Clarifying misbeliefs about hydroxychloroquine (HCQ): developing the HCQ benefits versus harm decision aid (HCQ-SAFE) per low health literacy standards
por: Garg, Shivani, et al.
Publicado: (2023)